Skip to main content
. 2023 Oct 19;28(20):7165. doi: 10.3390/molecules28207165

Figure 3.

Figure 3

The chemical structure of some marketed AMPs. For gramicidin D and teicoplanin, only the most abundant components of the clinically used mixtures are shown.